PTEN and neoplasm: The phosphatase and tensin homolog gene, PTEN, is one of the most commonly mutated tumor suppressors in human malignancies [1–5], and complete loss of PTEN protein expression is significantly associated with advanced cancer and poor outcome [6, 7].